Clinical Trial Update: Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating P-321 ophthalmic solution vs placebo in dry eye disease was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• P-321

Snippet

Sponsor: Parion Sciences | Conditions: Dry Eye Disease | Phase 2 | Status: TERMINATED | Results posted: 2018-10-11